KIR3DL1 Allotype-Dependent Modulation of NK Cell Immunity against Chronic Myeloid Leukemia.
Immunohorizons
; 5(8): 687-702, 2021 08 25.
Article
in En
| MEDLINE
| ID: mdl-34433624
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Killer Cells, Natural
/
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
/
Gene Expression Regulation, Leukemic
/
Receptors, KIR3DL1
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Immunohorizons
Year:
2021
Document type:
Article
Affiliation country:
Japan
Country of publication:
United States